Apelin (DrugBank: -)
1 disease| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 86 | Pulmonary arterial hypertension | 2 |
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01590108 (ClinicalTrials.gov) | March 2012 | 30/4/2012 | The Study of Apelin-APJ System on Pulmonary Hypertension Patients and Healthy Subjects | The Apelin-APJ System in Idiopathic Pulmonary Arterial Hypertension and Healthy Volunteers; Tissue Location and Cardiopulmonary Response. | Idiopathic Pulmonary Arterial Hypertension | Drug: (Pyr1)apelin-13;Drug: Saline | Imperial College London | NULL | Completed | 18 Years | 90 Years | Male | 12 | Phase 1 | United Kingdom |
| 2 | NCT01457170 (ClinicalTrials.gov) | January 2012 | 20/10/2011 | Effects of Apelin on the Lung Circulation in Pulmonary Hypertension | Investigating the Acute Pulmonary Vascular Haemodynamic Effects of Apelin in Pulmonary Hypertension | Pulmonary Arterial Hypertension;Heart Failure | Drug: Apelin;Drug: Saline (Placebo) | Golden Jubilee National Hospital | NHS Lothian;Imperial College Healthcare NHS Trust | Recruiting | 18 Years | N/A | Both | 63 | N/A | United Kingdom |